By Michael Dabaie

 

Becton Dickinson & Co. said attorneys general from 48 states and the District of Columbia unveiled a $60 million settlement with the company to resolve legacy litigation from C.R. Bard.

Medical technology company Becton said the litigation was initiated prior to its acquisition of Bard in 2017 and related to discontinued pelvic mesh products.

A statement from Connecticut Attorney General William Tong said the attorneys general allege that C.R. Bard misrepresented or failed to adequately disclose serious and life-altering risks of surgical mesh devices, such as chronic pain, scarring and shrinking of bodily tissue, painful sexual relations, and recurring infections, among other complications.

Becton said the company and Bard have denied any wrongdoing and all allegations included in the litigation and chose to settle the matter to avoid the time and expense of further litigation. The company said it is fully reserved for the settlement amount.

Becton Dickinson shares were down 2% to $221.34 in afternoon trading.

 

Write to Michael Dabaie at michael.dabaie@wsj.com

 

(END) Dow Jones Newswires

September 24, 2020 15:00 ET (19:00 GMT)

Copyright (c) 2020 Dow Jones & Company, Inc.
Becton Dickinson (NYSE:BDX)
Historical Stock Chart
From Sep 2020 to Oct 2020 Click Here for more Becton Dickinson Charts.
Becton Dickinson (NYSE:BDX)
Historical Stock Chart
From Oct 2019 to Oct 2020 Click Here for more Becton Dickinson Charts.